Skip to main content

Advertisement

SpringerLink
Log in

Central administration of oxytocin receptor ligands affects cued fear extinction in rats and mice in a timepoint-dependent manner

  • Original Investigation
  • Published:
Psychopharmacology Aims and scope Submit manuscript

Abstract

Rationale

Oxytocin (OXT) has been proposed as a potential therapeutic agent for post-traumatic stress disorder (PTSD).

Objectives

We aimed to verify whether pharmacological manipulation of the brain OXT system affects cued fear conditioning and fear extinction.

Methods

Male rats and mice were intracerebroventricularly administered synthetic OXT (rats, 0.1 or 1.0 μg/5 μl; mice, 0.1 or 0.5 μg/2 μl) and/or an OXT receptor antagonist (OXTR-A; rats, 0.75 μg/5 μl) either prior to fear conditioning or extinction training.

Results

Preconditioning administration of OXT did not affect fear conditioning in rats, but decreased fear expression and facilitated fear extinction. In contrast, preconditioning blockade of OXT neurotransmission by OXTR-A did not affect fear conditioning or fear expression, but impaired fear extinction. When administered before extinction training, OXT impaired fear extinction in both rats and mice, indicating that the effects of OXT on fear extinction are conserved across species. This impairment was OXTR-mediated, as the inhibitory effect of OXT on fear extinction was abolished by prior treatment with OXTR-A. The impaired fear extinction was not a result of reduced locomotion in rats, whereas an apparent decrease in fear expression and facilitation of fear extinction with the higher OXT dose in mice was the result of behavioral hyperactivity.

Conclusions

These results suggest that increasing OXT neurotransmission during traumatic events is likely to prevent the formation of aversive memories. In contrast, OXT treatment before fear extinction training, which would be the comparable timepoint for psychotherapy in PTSD patients, rather delays fear extinction and, therefore, caution is needed before recommending OXT for the treatment of PTSD.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  • Barrett D, Gonzalez-Lima F (2004) Behavioral effects of metyrapone on Pavlovian extinction. Neurosci Lett 371(2–3):91–96

    Article  PubMed  CAS  Google Scholar 

  • Bisson JI, Ehlers A, Matthews R, Pilling S, Richards D, Turner S (2007) Psychological treatments for chronic post-traumatic stress disorder. Systematic review and meta-analysis. Br J Psychiatry 190:97–104

    Article  PubMed  Google Scholar 

  • Blume A, Bosch OJ, Miklos S, Torner L, Wales L, Waldherr M, Neumann ID (2008) Oxytocin reduces anxiety via ERK 1/2 activation: local effect within the rat hypothalamic paraventricular nucleus. Eur J Neurosci 27:1947–1956

    Article  PubMed  Google Scholar 

  • Bohus B, Kovacs GL, de Wied D (1978) Oxytocin, vasopressin and memory: opposite effects on consolidation and retrieval processes. Brain Res 157:414–417

    Article  PubMed  CAS  Google Scholar 

  • Bosch OJ, Neumann ID (2008) Brain vasopressin is an important regulator of maternal behavior independent of dams' trait anxiety. Proc Natl Acad Sci 105(44):17139–17144

    Article  PubMed  CAS  Google Scholar 

  • Brunello N, Davidson JR, Deahl M, Kessler RC, Mendlewicz J, Racagni G, Shalev AY, Zohar J (2001) Posttraumatic stress disorder: diagnosis and epidemiology, comorbidity and social consequences, biology and treatment. Neuropsychobiology 43:150–162

    Article  PubMed  CAS  Google Scholar 

  • Cammarota M, Bevilaqua LR, Vianna MR, Medina JH, Izquierdo I (2007) The extinction of conditioned fear: structural and molecular basis and therapeutic use. Rev Bras Psiquiatr 29(1):80–85

    Article  PubMed  Google Scholar 

  • Carter CS, Altemus M, Chrousos GP (2001) Neuroendocrine and emotional changes in the post-partum period. Prog Brain Res 133:241–249

    Article  PubMed  CAS  Google Scholar 

  • Condés-Lara M, Rojas-Piloni G, Martínez-Lorenzana G, López-Hidalgo M, Rodríguez-Jiménez J (2009) Hypothalamospinal oxytocinergic antinociception is mediated by GABAergic and opiate neurons that reduce A-delta and C fiber primary afferent excitation of spinal cord cells. Brain Res 1247:38–49

    Article  PubMed  Google Scholar 

  • Conrad CD, Galea LAM, Kuroda Y, McEwen BS (1996) Chronic stress impairs spatial memory on the Y maze, and this effect is blocked by tianeptine pretreatment. Behav Neurosci 110:1321–1334

    Article  PubMed  CAS  Google Scholar 

  • Cordero MI, Sandi C (1998) A role for brain glucocorticoid receptors in contextual fear conditioning: dependence upon training intensity. Brain Res 786(1–2):11–17

    Article  PubMed  CAS  Google Scholar 

  • Cordero MI, Kruyt ND, Merino JJ, Sandi C (2002) Glucocorticoid involvement in memory formation in a rat model for traumatic memory. Stress 5(1):73–79

    Article  PubMed  CAS  Google Scholar 

  • Davidson JR, Stein DJ, Shalev AY, Yehuda R (2004) Posttraumatic stress disorder: acquisition, recognition, course, and treatment. J Neuropsychiatry Clin Neurosci 16:135–147

    Article  PubMed  Google Scholar 

  • de Kloet ER, Oitzl MS, Joels M (1999) Stress and cognition, are corticosteroids good or bad guys? Trends Neurosci 22:422–426

    Article  PubMed  Google Scholar 

  • de Wied D, Elands J, Kovacs G (1991) Interactive effects of neurohypophyseal neuropeptides with receptor antagonists on passive avoidance behavior: mediation by a cerebral neurohypophyseal hormone receptor. Proc Natl Acad Sci USA 88:1494–1498

    Article  PubMed  Google Scholar 

  • Delanoy RL, Dunn AJ, Walter R (1979) Neurohypophyseal hormones and behavior: effects of intracerebroventricularly injected hormone analogs in mice. Life Sci 24:651–658

    Article  PubMed  CAS  Google Scholar 

  • Dilger S, Straube T, Mentzel HJ, Fitzek C, Reichenbach JR, Hecht H, Krieschel S, Gutberlet I, Miltner WH (2003) Brain activation to phobia-related pictures in spider phobic humans: an event-related functional magnetic resonance imaging study. Neurosci Lett 348:29–32

    Article  PubMed  CAS  Google Scholar 

  • Ebner K, Bosch OJ, Krömer SA, Singewald N, Neumann ID (2005) Release of oxytocin in the rat central amygdala modulates stress-coping behavior and the release of excitatory amino acids. Neuropsychopharmacol 30(2):223–230

    Article  CAS  Google Scholar 

  • Fanselow MS (1980) Conditioned and unconditional components of post-shock freezing. Pavlov J Biol Sci 15(4):177–182

    PubMed  CAS  Google Scholar 

  • Fleshner M, Pugh CR, Tremblay D, Rudy JW (1997) DHEA-S selectively impairs contextual-fear conditioning: support for the antiglucocorticoid hypothesis. Behav Neurosci 111(3):512–517

    Article  PubMed  CAS  Google Scholar 

  • Gülpinar MA, Yegen BC (2004) The physiology of learning and memory: role of peptides and stress. Curr Protein Pept Sci 5(6):457–473

    Article  PubMed  Google Scholar 

  • Heinrichs M, Meinlschmidt G, Neumann ID, Wagner S, Kirschbaum C, Ehlert U, Hellhammer DH (2001) Effects of suckling on hypothalamic–pituitary–adrenal axis responses to psychosocial stress in postpartum lactating women. J Clin Endocrinol Metab 86:4798–4804

    Article  PubMed  CAS  Google Scholar 

  • Heinrichs M, Baumgartner T, Kirschbaum C, Ehlert U (2003) Social support and oxytocin interact to suppress cortisol and subjective responses to psychosocial stress. Biol Psychiatry 54:1389–1398

    Article  PubMed  CAS  Google Scholar 

  • Herry C, Trifilieff P, Micheau J, Luthi A, Mons N (2006) Extinction of auditory fear conditioning requires MAPK/ERK activation in the basolateral amygdala. Eur J Neurosci 24:261–269

    Article  PubMed  Google Scholar 

  • Herry C, Ciocchi S, Senn V, Demmou L, Muller C, Luthi A (2008) Switching on and off fear by distinct neuronal circuits. Nature 454:600–606

    Article  PubMed  CAS  Google Scholar 

  • Ipser J, Seedat S, Stein DJ (2006) Pharmacotherapy for post-traumatic stress disorder—a systematic review and meta-analysis. S Afr Med J 96:1088–1096

    PubMed  CAS  Google Scholar 

  • Kaidanovich-Beilin O, Lipina TV, Takao K, van Eede M, Hattori S, Laliberté C, Khan M, Okamoto K, Chambers JW, Fletcher PJ, MacAulay K, Doble BW, Henkelman M, Miyakawa T, Roder J, Woodgett JR (2009) Abnormalities in brain structure and behavior in GSK-3alpha mutant mice. Mol Brain 19:2–35

    Google Scholar 

  • Kirsch P, Esslinger C, Chen Q, Mier D, Lis S, Siddhanti S, Gruppe H, Mattay VS, Gallhofer B, Meyer-Lindenberg A (2005) Oxytocin modulates neural circuitry for social cognition and fear in humans. J Neurosci 25(49):11489–11493

    Article  PubMed  CAS  Google Scholar 

  • Kirschbaum C, Wolf OT, May M, Wippich W, Hellhammer DH (1996) Stress- and treatment-induced elevations of cortisol levels associated with impaired declarative memory in healthy adults. Life Sci 58:1475–1483

    Article  PubMed  CAS  Google Scholar 

  • Kovács GL, Bohus B, Versteeg DHG, de Kolet ER, de Wied D (1979) Effect of oxytocin and vasopressin on memory consolidation: sites of action and catecholaminergic correlates after local microinjection into limbic–midbrain structures. Brain Res 175:303–314

    Article  PubMed  Google Scholar 

  • Labuschagne I, Phan KL, Wood A, Angstadt M, Chua P, Heinrichs M, Stout JC, Nathan PJ (2010) Oxytocin attenuates amygdala reactivity to fear in generalized social anxiety disorder. Neuropsychopharmacol 35(12):2403–2413

    Article  CAS  Google Scholar 

  • Landgraf R, Neumann ID (2004) Vasopressin and oxytocin release within the brain: a dynamic concept of multiple and variable modes of neuropeptide communication. Front Neuroendocrinol 25:150–176

    Article  PubMed  CAS  Google Scholar 

  • Lattal KM, Abel T (2001) Different requirements for protein synthesis in acquisition and extinction of spatial preferences and context-evoked fear. J Neurosci 21(15):5773–5780

    PubMed  CAS  Google Scholar 

  • LeDoux JE, Iwata J, Cicchetti P, Reis DJ (1988) Different projections of the central amygdaloid nucleus mediate autonomic and behavioral correlates of conditioned fear. J Neurosci 8:2517–2529

    PubMed  CAS  Google Scholar 

  • Likhtik E, Popa D, Apergis-Schoute J, Fidacaro GA, Paré D (2008) Amygdala intercalated neurons are required for expression of fear extinction. Nature 454:642–645

    Article  PubMed  CAS  Google Scholar 

  • Loscertales M, Rose SP, Sandi C (1997) The corticosteroid synthesis inhibitors metyrapone and aminoglutethimide impair long-term memory for a passive avoidance task in day-old chicks. Brain Res 769(2):357–361

    Article  PubMed  CAS  Google Scholar 

  • Lukas M, Toth I, Reber SO, Slattery DA, Veenema AH, Neumann ID (2011) The neuropeptide oxytocin facilitates pro-social behavior and prevents social avoidance in rats and mice. Neuropsychopharmacol 36(11):2159–2168

    Article  CAS  Google Scholar 

  • Lundeberg T, Uvnäs-Moberg K, Agren G, Bruzelius G (1994) Anti-nociceptive effects of oxytocin in rats and mice. Neurosci Lett 28;170(1):153–157

    Google Scholar 

  • Lupien SJ, McEwen BS (1997) The acute effects of corticosteroids on cognition: integration of animal and human model studies. Brain Res Rev 24:1–27

    Article  PubMed  CAS  Google Scholar 

  • Makkar SR, Zhang SQ, Cranney J (2010) Behavioral and neural analysis of GABA in the acquisition, consolidation, reconsolidation, and extinction of fear memory. Neuropsychopharmacol 35:1625–1652

    CAS  Google Scholar 

  • Manning M, Stoev S, Chini B, Durroux T, Mouillac B, Guillon G (2008) Peptide and non-peptide agonists and antagonists for the vasopressin and oxytocin V1a, V1b, V2 and OT receptors: research tools and potential therapeutic agents. Prog Brain Res 170:473–512

    Article  PubMed  CAS  Google Scholar 

  • Marshall RD, Pierce D (2000) Implications of recent findings in posttraumatic stress disorder and the role of pharmacotherapy. Harv Rev Psychiatry 7(5):247–256

    PubMed  CAS  Google Scholar 

  • McCarthy MM, McDonald CH, Brooks PJ, Goldman D (1996) An anxiolytic action of oxytocin is enhanced by estrogen in the mouse. Physiol Behav 60(5):1209–1215

    Article  PubMed  CAS  Google Scholar 

  • Meisenberg G, Simmons WH (1982) Behavioral effects of intracerebroventricularly administered neurohypophyseal hormone analogs in mice. Pharmac Biochem Behav 16:819–825

    Article  CAS  Google Scholar 

  • Muigg P, Hetzenauer A, Hauer G, Hauschild M, Gaburro S, Frank E, Landgraf R, Singewald N (2008) Impaired extinction of learned fear in rats selectively bred for high anxiety—evidence of altered neuronal processing in prefrontal–amygdala pathways. Eur J Neurosci 28(11):2299–2309

    Article  PubMed  Google Scholar 

  • Myers KM, Davis M (2002) Behavioral and neural analysis of extinction. Neuron 36(4):567–584

    Article  PubMed  CAS  Google Scholar 

  • Neumann ID (2007) Stimuli and consequences of dendritic release of oxytocin within the brain. Biochem Soc Trans 35(5):1252–1257

    Article  PubMed  CAS  Google Scholar 

  • Neumann ID, Wigger A, Torner L, Holsboer F, Landgraf R (2000) Brain oxytocin inhibits basal and stress-induced activity of the hypothalamo-pituitary-adrenal axis in male and female rats: partial action within the paraventricular nucleus. J Neuroendocrinol 12(3):235–243

    Article  PubMed  CAS  Google Scholar 

  • Olff M, Langeland W, Witteveen A, Denys D (2010) A psychobiological rationale for oxytocin in the treatment of posttraumatic stress disorder. CNS Spectr 15(8):522–530

    PubMed  Google Scholar 

  • Quirk GJ, Likhtik E, Pelletier JG, Paré D (2003) Stimulation of medial prefrontal cortex decreases the responsiveness of central amygdala output neurons. J Neurosci 23:8800–8807

    PubMed  CAS  Google Scholar 

  • Quirk GJ, Paré D, Richardson R, Herry C, Monfils MH, Schiller D, Vicentic A (2010) Erasing fear memories with extinction training. J Neurosci 30(45):14993–14997

    Article  PubMed  CAS  Google Scholar 

  • Rauch SL, Whalen PJ, Shin LM, McInerney SC, Macklin ML, Lasko NB, Orr SP, Pitman RK (2000) Exaggerated amygdala response to masked facial stimuli in posttraumatic stress disorder: a functional MRI study. Biol Psychiatry 47:769–776

    Article  PubMed  CAS  Google Scholar 

  • Ring RH, Malberg JE, Potestio L, Ping J, Boikess S, Luo B, Schechter LE, Rizzo S, Rahman Z, Rosenzweig-Lipson S (2006) Anxiolytic-like activity of oxytocin in male mice: behavioral and autonomic evidence, therapeutic implications. Psychopharmacology (Berl) 185(2):218–225

    Article  CAS  Google Scholar 

  • Roozendaal B, Schoorlemmer GH, Wiersma A, Sluyter S, Driscoll P, Koolhaas JM, Bohus B (1992) Opposite effects of central amygdaloid vasopressin and oxytocin on the regulation of conditioned stress responses in male rats. Ann NY Acad Sci 652:460–461

    Article  PubMed  CAS  Google Scholar 

  • Sandi C (1998) Role and mechanisms of action of glucocorticoids in memory formation. Neural Plasticity 6:39–49

    Article  Google Scholar 

  • Shin LM, Orr SP, Carson MA, Rauch SL, Macklin ML, Lasko NB, Peters PM, Metzger LJ, Dougherty DD, Cannistraro PA, Alpert NM, Fischman AJ, Pitman RK (2004) Regional cerebral blood flow in the amygdala and medial prefrontal cortex during traumatic imagery in male and female Vietnam veterans with PTSD. Arch Gen Psychiatry 61:168–176

    Article  PubMed  Google Scholar 

  • Slattery DA, Neumann ID (2008) No stress please! Mechanisms of stress hyporesponsiveness of the maternal brain. J Physiol 586(2):377–385

    Article  PubMed  CAS  Google Scholar 

  • Slattery DA, Uschold N, Magoni M, Bär J, Popoli M, Neumann ID, Reber SO (2012) Behavioural consequences of two chronic psychosocial stress paradigms: anxiety without depression. Psychoneuroendocrinol 37(5):702–714

    Article  Google Scholar 

  • Sotres-Bayon F, Bush DE, LeDoux JE (2007) Acquisition of fear extinction requires activation of NR2B-containing NMDA receptors in the lateral amygdala. Neuropsychopharmacol 32:1929–1940

    Article  CAS  Google Scholar 

  • Stein MB, Goldin PR, Sareen J, Zorrilla LT, Brown GG (2002) Increased amygdala activation to angry and contemptuous faces in generalized social phobia. Arch Gen Psychiatry 59:1027–1034

    Article  PubMed  Google Scholar 

  • Stein DJ, Ipser JC, Seedat S (2006) Pharmacotherapy for post traumatic stress disorder (PTSD). Cochrane Database Syst Rev (1):CD002795

  • Stein DJ, Ipser J, McAnda N (2009) Pharmacotherapy of posttraumatic stress disorder: a review of meta-analyses and treatment guidelines. CNS Spectr 14:25–31

    PubMed  Google Scholar 

  • Takao K, Tanda K, Nakamura K, Kasahara J, Nakao K, Katsuki M, Nakanishi K, Yamasaki N, Toyama K, Adachi M, Umeda M, Araki T, Fukunaga K, Kondo H, Sakagami H, Miyakawa T (2010) Comprehensive behavioral analysis of calcium/calmodulin-dependent protein kinase IV knockout mice. PLoS One 5(3):e9460

    Article  PubMed  Google Scholar 

  • Toth I, Dietz M, Peterlik D, Huber SE, Fendt M, Neumann ID, Flor PJ, Slattery DA (2012a) Pharmacological interference with metabotropic glutamate receptor subtype 7 but not subtype 5 differentially affects within- and between-session extinction of Pavlovian conditioned fear. Neuropharmacol 62(4):1619–1626

    Article  CAS  Google Scholar 

  • Toth I, Neumann ID, Slattery DA (2012b) Social fear conditioning: a novel and specific animal model to study social anxiety disorder. Neuropsychopharmacology. doi:10.1038/npp.2011.329

  • Uvnäs-Moberg K, Bruzelius G, Alster P, Bileviciute I, Lundeberg T (1992) Oxytocin increases and a specific oxytocin antagonist decreases pain threshold in male rats. Acta Physiol Scand 144(4):487–488

    Article  PubMed  Google Scholar 

  • Uvnäs-Moberg K, Ahlenius S, Hillegaart V, Alster P (1994) High doses of oxytocin cause sedation and low doses cause an anxiolytic-like effect in male rats. Pharmacol Biochem Behav 49(1):101–106

    Article  PubMed  Google Scholar 

  • Viero C, Shibuya I, Kitamura N, Verkhratsky A, Fujihara H, Katoh A, Ueta Y, Zingg HH, Chvatal A, Sykova E, Dayanithi G (2010) Oxytocin: crossing the bridge between basic science and pharmacotherapy. CNS Neurosci Ther 16(5):138–156

    Article  Google Scholar 

  • Viviani D, Charlet A, van den Burg E, Robinet C, Hurni N, Abatis M, Magara F, Stoop R (2011) Oxytocin selectively gates fear responses through distinct outputs from the central amygdala. Science 333(6038):104–107

    Article  PubMed  CAS  Google Scholar 

  • Waldherr M, Neumann ID (2007) Centrally released oxytocin mediates mating-induced anxiolysis in male rats. Proc Natl Acad Sci USA 104(42):16681–16684

    Article  PubMed  CAS  Google Scholar 

  • Weeber EJ, Atkins CM, Selcher JC, Varga AW, Mirnikjoo B, Paylor R, Leitges M, Sweatt JD (2000) A role for the beta isoform of protein kinase C in fear conditioning. J Neurosci 20(16):5906–5914

    PubMed  CAS  Google Scholar 

  • Windle RJ, Shanks N, Lightman SL, Ingram CD (1997) Central oxytocin administration reduces stress-induced corticosterone release and anxiety behavior in rats. Endocrinol 138:2829–2834

    Article  CAS  Google Scholar 

  • Wotjak CT, Landgraf R, Engelmann M (2008) Listening to neuropeptides by microdialysis: echoes and new sounds? Pharmacol Biochem Behav 90(2):125–134

    Article  PubMed  CAS  Google Scholar 

  • Yang YL, Chao PK, Lu KT (2006) Systemic and intra-amygdala administration of glucocorticoid agonist and antagonist modulate extinction of conditioned fear. Neuropsychopharmacol 31(5):912–924

    Article  CAS  Google Scholar 

  • Yang YL, Chao PK, Ro LS, Wo YY, Lu KT (2007) Glutamate NMDA receptors within the amygdala participate in the modulatory effect of glucocorticoids on extinction of conditioned fear in rats. Neuropsychopharmacol 32(5):1042–1051

    Article  CAS  Google Scholar 

  • Yang J, Liang JY, Zhang XY, Qiu PY, Pan YJ, Li P, Zhang J, Hao F, Wang DX, Yan FL (2011) Oxytocin, but not arginine vasopressin is involving in the antinociceptive role of hypothalamic supraoptic nucleus. Peptides 32(5):1042–1046

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

We thank Dr. Maurice Manning for generously providing the oxytocin receptor antagonist. We also thank Rodrigue Maloumby, Andreas Thuy, and Doris Bayerl for the technical assistance. IT received financial support from the Bayerische Forschungsstiftung. IDN received financial support from BMBF and Deutsche Forschungsgemeinschaft.

Disclosure/conflict of interest

The authors report no biomedical financial interest or potential conflict of interest.

Author information

Authors and Affiliations

  1. Department of Behavioral and Molecular Neurobiology, Faculty of Biology and Preclinical Medicine, University of Regensburg, Universitätsstraße 31, 93053, Regensburg, Germany

    Iulia Toth, Inga D. Neumann & David A. Slattery

Authors
  1. Iulia Toth
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Inga D. Neumann
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. David A. Slattery
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to David A. Slattery.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Toth, I., Neumann, I.D. & Slattery, D.A. Central administration of oxytocin receptor ligands affects cued fear extinction in rats and mice in a timepoint-dependent manner. Psychopharmacology 223, 149–158 (2012). https://doi.org/10.1007/s00213-012-2702-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00213-012-2702-4

Keywords

Search

Navigation